US
CA
NZ
UK
AU
IND
Last update at 2025-05-21T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Swiss insurers Helvetia and Baloise to merge to create top 10 company
Tue 22 Apr 25, 05:17 AMActivist investor Cevian ups stake in Baloise to 9.4%
Mon 09 Sep 24, 04:37 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 682.90M | 697.90M | 568.60M | 686.20M | 697.60M |
| Minority interest | 3.50M | 5.10M | 2.00M | 1.60M | 37.60M |
| Net income | 548.00M | 588.40M | 434.30M | 694.20M | 523.20M |
| Selling general administrative | 867.00M | 856.70M | 24.90M | 19.50M | 810.80M |
| Selling and marketing expenses | - | 46.20M | 41.60M | 59.90M | - |
| Gross profit | 7447.10M | 8833.70M | 8142.30M | 9428.60M | 7897.50M |
| Reconciled depreciation | 98.20M | 102.00M | 97.10M | 90.80M | 67.10M |
| Ebit | 666.40M | 681.00M | 575.40M | 683.80M | 647.90M |
| Ebitda | 764.60M | 783.00M | 672.50M | 774.60M | 715.00M |
| Depreciation and amortization | 98.20M | 102.00M | 97.10M | 90.80M | 67.10M |
| Non operating income net other | - | - | - | - | 0.00000M |
| Operating income | 666.40M | 681.00M | 575.40M | 683.80M | 647.90M |
| Other operating expenses | 6764.30M | 8136.00M | 7573.80M | 8742.50M | 6398.70M |
| Interest expense | 34.00M | 38.30M | 49.50M | 51.60M | 64.40M |
| Tax provision | 138.40M | 114.60M | 140.30M | -3.30000M | 174.70M |
| Interest income | 5.70M | 8.00M | 16.00M | 11.50M | 15.10M |
| Net interest income | -34.00000M | -1198.60000M | -292.70000M | -120.80000M | -111.90000M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | 0.00000M |
| Other items | - | - | - | - | 0.00000M |
| Income tax expense | 138.40M | 114.60M | 140.30M | -3.30000M | 174.70M |
| Total revenue | 7447.10M | 8833.70M | 8142.30M | 9428.60M | 7897.50M |
| Total operating expenses | 6764.30M | 7653.20M | 7959.10M | 8947.70M | 7440.50M |
| Cost of revenue | - | - | - | 7484.70M | 5944.50M |
| Total other income expense net | 20.00M | 22.00M | -0.80000M | 7.10M | 50.00M |
| Discontinued operations | - | - | - | - | 0.00000M |
| Net income from continuing ops | 544.50M | 583.30M | 428.30M | 689.50M | 522.90M |
| Net income applicable to common shares | - | 588.40M | 434.30M | 694.20M | 523.20M |
| Preferred stock and other adjustments | - | - | - | - | 0.00000M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 77872.80M | 80550.10M | 89979.00M | 88364.50M | 87017.80M |
| Intangible assets | 122.70M | 143.00M | 168.70M | 195.40M | 194.10M |
| Earning assets | - | - | - | - | - |
| Other current assets | 4771.20M | - | 2094.30M | 1995.50M | 1901.60M |
| Total liab | 74613.50M | 75998.00M | 82679.10M | 81378.80M | 80302.20M |
| Total stockholder equity | 3250.00M | 4539.50M | 7285.10M | 6983.70M | 6714.00M |
| Deferred long term liab | - | 1166.60M | 911.80M | 856.90M | 759.80M |
| Other current liab | -113.00000M | -746.70000M | -706.10000M | -566.20000M | -668.00000M |
| Common stock | 4.60M | 4.60M | 4.60M | 4.90M | 4.90M |
| Capital stock | 4.60M | 4.60M | 4.60M | 4.90M | 4.90M |
| Retained earnings | 4808.30M | 7040.10M | 6809.70M | 6983.00M | 6839.40M |
| Other liab | - | 60927.00M | 66964.90M | 66481.60M | 65711.30M |
| Good will | 92.10M | 96.30M | 99.90M | 103.10M | 80.70M |
| Other assets | -54866.70000M | -850.30000M | -6393.00000M | -4751.70000M | -3575.20000M |
| Cash | 2985.30M | 3370.20M | 4073.50M | 4004.00M | 3988.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 50220.30M | 746.70M | 706.10M | 566.20M | 668.00M |
| Current deferred revenue | 56.50M | - | - | - | - |
| Net debt | 2263.10M | 1514.20M | 924.20M | 770.30M | -1620.00000M |
| Short term debt | 189.60M | - | - | - | - |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 5248.40M | 4884.40M | 4997.70M | 4774.30M | 2368.00M |
| Other stockholder equity | -1562.90000M | -2505.20000M | 470.80M | -4.20000M | -130.30000M |
| Property plant equipment | - | - | 419.50M | 466.20M | 362.80M |
| Total current assets | 8976.70M | 30884.60M | 37258.00M | 36097.80M | 35440.60M |
| Long term investments | 48477.00M | 49644.10M | 58333.10M | 56113.20M | 54417.40M |
| Net tangible assets | - | - | 7019.30M | 6688.90M | 6443.70M |
| Short term investments | 5991.40M | 27514.40M | 33184.50M | 32093.80M | 31452.60M |
| Net receivables | - | 593.50M | 827.40M | 889.20M | 904.50M |
| Long term debt | 5191.10M | 4858.50M | 4971.20M | 4735.40M | 2325.00M |
| Inventory | - | - | - | - | - |
| Accounts payable | 49819.50M | 746.70M | 706.10M | 566.20M | 668.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -1892.70000M | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 74224.80M | -50515.80000M | -59114.00000M | -57018.40000M | -55152.40000M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 123762.80M | 50515.80M | 59114.00M | 57018.40M | 55152.40M |
| Capital lease obligations | 57.30M | 25.90M | 26.50M | 38.90M | 43.00M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -74.30000M | -52.70000M | 182.80M | -157.40000M | -81.30000M |
| Change to liabilities | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
| Total cashflows from investing activities | - | -94.30000M | 382.90M | -472.60000M | -142.40000M |
| Net borrowings | 172.60M | 61.70M | -17.20000M | 562.80M | 562.80M |
| Total cash from financing activities | -155.80000M | -238.90000M | -431.50000M | 58.00M | -441.70000M |
| Change to operating activities | - | 1692.40M | 23.30M | 1863.20M | -656.10000M |
| Net income | 682.90M | 697.90M | 568.60M | 686.20M | 697.60M |
| Change in cash | -703.30000M | 69.50M | 16.00M | -48.10000M | 484.50M |
| Begin period cash flow | 4073.50M | 4004.00M | 3988.00M | 4036.10M | 3551.60M |
| End period cash flow | 3370.20M | 4073.50M | 4004.00M | 3988.00M | 4036.10M |
| Total cash from operating activities | -388.00000M | 477.00M | 80.80M | 439.70M | 1132.60M |
| Issuance of capital stock | 54.50M | 65.20M | 68.20M | 79.10M | 58.50M |
| Depreciation | 98.20M | 102.00M | 97.10M | 90.80M | 67.10M |
| Other cashflows from investing activities | -0.10000M | -0.10000M | -0.10000M | -0.10000M | 0.10M |
| Dividends paid | -316.50000M | -288.40000M | -287.40000M | -278.60000M | 264.00M |
| Change to inventory | - | - | - | - | 0.00000M |
| Change to account receivables | -99.20000M | -87.40000M | -52.00000M | -131.40000M | 140.40M |
| Sale purchase of stock | -45.30000M | -51.60000M | -158.00000M | -266.70000M | -192.00000M |
| Other cashflows from financing activities | 501.50M | 410.90M | 245.70M | 699.20M | -44.20000M |
| Change to netincome | - | -1815.30000M | -423.00000M | -2071.90000M | 1058.00M |
| Capital expenditures | 45.90M | 49.40M | 71.30M | 82.00M | 83.40M |
| Change receivables | - | - | - | - | 0.00000M |
| Cash flows other operating | - | - | - | - | 0.00000M |
| Exchange rate changes | - | - | - | - | 0.00000M |
| Cash and cash equivalents changes | - | - | - | - | 0.00000M |
| Change in working capital | -2792.80000M | 3162.00M | 497.40M | 3136.10M | -528.10000M |
| Stock based compensation | 6.00M | 5.30M | 9.00M | - | - |
| Other non cash items | 1617.70M | -3490.20000M | -1091.30000M | -3473.40000M | 896.00M |
| Free cash flow | -433.90000M | 427.60M | 9.50M | 357.70M | 1049.20M |
Sector: Financial Services Industry: Insurance - Diversified
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) |
|---|---|---|---|---|---|---|---|
| BLHEF Bâloise Holding AG |
-0.0005 0.0002% | 227.98 | 31.63 | 12.80 | 1.55 | 2.28 | 1.53 |
| ALIZY Allianz SE ADR |
-0.02 0.05% | 39.51 | 12.24 | 11.61 | 1.25 | 2.01 | 1.11 |
| ALIZF Allianz SE |
- -% | 394.00 | 12.22 | 11.71 | 1.24 | 2.03 | 1.11 |
| AXAHY Axa SA ADR |
-0.1 0.21% | 46.87 | 10.45 | 9.17 | 0.87 | 1.57 | 1.38 |
| ZURVY Zurich Insurance Group Ltd |
-0.11 0.31% | 35.11 | 16.20 | 14.47 | 1.67 | 3.13 | 1.24 |
Baloise Holding AG, together with its subsidiaries, primarily engages in the insurance and banking businesses in Switzerland, Germany, Belgium, Luxembourg. It operates through Non-Life, Life, Asset Management & Banking, and Other Activities segments. The company offers various non-life insurance products, including accident, health, general liability, motor, fire and other property, marine, credit protection, and legal expenses insurance. It provides life insurance products, which include endowment policies, such as conventional and unit-linked life insurance; group life insurance products; term insurance; annuities; and policy riders. In addition, the company engages in the banking activities in Switzerland; and offers asset management services. Further, it has interests in equity investment companies, real-estate firms, and financing companies. It sells its products and services to individuals, small and medium sized enterprises, and industrial clients. Baloise Holding AG was founded in 1863 and is headquartered in Basel, Switzerland.
Aeschengraben 21, Basel, Switzerland, 4002
| Name | Title | Year Born |
|---|---|---|
| Mr. Gert De Winter M.Sc. | Group Chief Exec. Officer | 1966 |
| Dr. Carsten Stolz | Head of Corp. Fin. Division & CFO | 1968 |
| Mr. Matthias Henny Dr Phil | Head of Corp. Division Asset Management & Chief Investment Officer | 1971 |
| Dr. Alexander Bockelmann | Head of Corp. Division IT & CTO | 1974 |
| Mr. Michael Muller | Head of Corp. Division Switzerland & CEO of Basler Switzerland | 1971 |
| Mr. Clemens Markstein | Head of Operations & IT - Switzerland | 1971 |
| Pierre Girard | Head of Group Accounting & Reporting | NA |
| Mr. Markus Holtz | Head of Investor Relations | 1978 |
| Mr. Peter Kalberer | Head of Group Compliance | NA |
| Andreas Burki | Head of Group Legal and Tax | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...